Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia

NCT03318419 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Cladribine
DRUG: G-CSF
DRUG: Cytarabine
DRUG: Pegaspargase

Sponsor

Sun Yat-sen University